Q&A: HDV Management Episode 2
In this podcast episode, listen to expert faculty perspectives on HDV management, including limitations to AASLD screening recommendations, use of double reflex testing, approaches to staging advanced liver disease, considerations for treatment, and clinical trial updates .
Decera Clinical Education Infectious Disease Podcast · Tatyana Kushner MD MSCE, Stefan Zeuzem MD
Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this episode, Tatyana Kushner, MD, MSCE, and Stefan Zeuzem, MD, address key considerations when screening, diagnosing, and treating patients with HDV, such as:
- Barriers to HDV screening, including limitations to AASLD guideline recommendations
- Use of double reflex testing to improve HDV diagnosis
- Considerations for repeat HDV testing in patients who are HBsAg positive who previously tested negative for HDV
- Updated CDC recommendations for HBV screening for all adults using a triple panel test
- Staging advanced liver disease in patients with HDV
- Indications for HDV treatment, including patients with low ALT levels and advanced or progressive liver disease
- Treatment landscape for HDV
- Personal experiences with use of pegylated interferon for HDV treatment, including considerations for use in patients with compensated cirrhosis
- Updates on novel HDV therapies, including:
- Summary of efficacy data on bulevirtide from clinical trials
- Interpretation of results from D-LIVR, a phase III trial assessing the safety and efficacy of lonafarnib
Link to full program:
bit.ly/3yp1Lxf
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.